Moderna Says It’s Scaling Back Vaccine Trials Because Of US Resistance
“You cannot make a return on investment if you don’t have access to the U.S. market," CEO Stéphane Bancel said. In other news, the chairman of the Advisory Committee on Immunization Practices suggested in a podcast that the public might want to reconsider the use of polio vaccines.